updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data oct
rate updat oct
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
remain top-tier competitor sever attract medic
market includ orthoped implant medic surgic
equip neurovascular product enjoy long record
innov key market anticip pattern
continu allow wide-moat compani earn attract
contrast rival zimmer biomet sought diversifi
eas relianc larg joint reconstruct benefit
strategi becam clear great recess push
orthoped market slow-growth mode demonstr
histor recession-resist busi inde vulner
mani uneasi patient defer elect procedur stryker
also rel less vulner increas price pressur
hip knee alway like presenc
medical-surg equip area offer measur
stabil diminish impact period econom
downturn vari product line also mean
opportun engin meaning innov critic
gain price advantag continu pursu
strategi augment intern innov acquisit
bone innov mako fit firm
larger goal partner close hospit custom
across multipl devic equip categori
see opportun optim synergist
innov across diverg busi segment
extens breadth product nonetheless serv stryker
well hospit custom seek consolid supplier order
take advantag volum discount moreov stryker
manag demonstr acut understand new
opportun med-tech competitor arisen thank
shift toward value-bas reimburs squeez
provid anticip continu make strateg
acquisit technolog product aim avoid
complic cut cost
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
design manufactur market array medic equip
instrument consum suppli implant devic product
portfolio includ hip knee replac endoscopi system oper
room equip embol coil spinal devic remain one
three largest competitor reconstruct orthoped implant
hold leadership posit oper room equip approxim
total revenu current come outsid unit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
stand behind fair valu estim per
share continu hold robust expect growth
knee mako robot trauma extrem medic
product neurovascular next five year
becom confid oper chang
firm implement lead sustain gain
effici sale perform addit think
could take time zimmer biomet catch
placement robot oper margin
hover histor rang around low
expect firm increas adjust oper margin
basi point thank product mix shift
on-going restructur effort
remain favor overal revenu growth
profit procedur volum healthcar
util demonstr solid growth sinc
assum stronger growth european region
wake reorgan even though price
pressur ratchet estim stryker
increas revenu annual
think reconstruct segment see growth around
annual hip grow line market
knee outpac market thank mako greater
price pressur larg joint gener complement
stronger growth trauma extrem expect
medical-surg segment grow around led
medic product project neurotech/spin
segment increas annual averag next
year double-digit growth neurotech off-set
basi averag volatil cash flow
divers product portfolio rate uncertainti
bullish scenario assum reconstruct
grow faster rate aid growth
trauma extrem well growth
top-lin sale add averag annual growth
case reform sale market structur
anticip boost spend
moder initi expect result
improv adjust oper margin
case peg fair valu per share
valu bear-cas scenario reflect
mid-single-digit growth knee assum
greater-than-expect price pressur increas
rel matur technolog competit inroad
zimmer biomet also assum edg
trauma extrem competitor success
launch product medical-surg segment
grow temper rate competit pressur
come weaker-than-expect spine
sale off-set growth neurotech project
adjust oper margin peak
manufactur cost fall slightli partial off-set
dug wide econom moat thank
competit advantag across key busi think
orthoped segment remain moatiest divis
signific switch cost surgeon
still influenti decision-mak implant brand
choic extens tool use prepar bone
instal implant standard differ
compani long learn curv becom profici
use compani instrument moreov rel
specialist orthoped surgeon skill
experi play outsiz role clinic outcom
patient factor leav surgeon reluct
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
intang asset contribut firm sustain
competit advantag
medic devic equip orthoped sale rep play
critic role surgeon sale rep present
everi procedur teach surgeon use tool
kit prepar select instrument
right size sequenc procedur
orthoped surgeon may perform hip
replac knee replac year sale
rep provid valuabl servic small group
high-volum surgeon may perform five knee
replac day less need train
sale rep surgeon may wish hire nurs
handl procedur prepar howev
busi quit moati
orthoped firm enjoy sustain advantag
particular intellectu properti keep
new entrant competitor bay firm own
roughli patent around globe act assert
enforc follow chang patent
 switch
first-inventor-to-fil system previous
first-to-inv system think chang favor
moat larger competitor new
system reward compani file time
manner comprehens understand
futur applic technolog deep
pocket oppos newli grant patent rival
end think legal chang translat
challeng patent firm like support
larg legal team better posit take
advantag new law convers new law erect
hurdl keep emerg upstart firm becom
seriou threat peer
train master multipl
especi procedur volum low maintain high
surgic facil one system surgeon
prefer certain vendor stretch back
day resid train research found surgeon
stick prefer vendor sale rep beyond
year use vendor approxim
orthoped procedur time switch
train develop relationship new sale
rep work less effici earli period
risk patient reduc number procedur
incom surgeon dynam explain
market share among four top orthoped implant maker
remain remark steadi past decad
market share knee implant hover around
zimmer biomet depuy also held share
respect common avenu
signific durabl share gain
relationship sale rep surgeon
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
owe chang competit condit
orthoped implant market zimmer acquir
smaller rival biomet consolid
orthoped implant maker taken one midtier competitor
pictur make like
hospit want purchas three top-tier
johnson zimmer biomet account
three fourth train orthoped surgeon pool even
orthoped surgeon longer enjoy complet autonomi
brand choic switch cost face remain real
hospit need balanc need cost save
consolid vendor
challeng
accommod mani surgeon possibl brand
choic biomet acquisit mean fewer hospit
need choos combin top-tier
midtier supplier rais likelihood stryker
remain oper room
expect price remain pressur payer
continu whittl away reimburs joint-reconstruct
procedur payment reform would
surpris see medicar cut reimburs
demand expect rise thank first babi boomer
reach key age window knee replac
implant account roughli one third half
procedur reimburs medicar
find much difficult justifi price increas
reimburs remain pressur erod reimburs
also mean orthoped procedur
histor profit center hospit less
profit also suggest orthoped surgeon
less influenc hospit institut shift
cardiovascular neurosurgeri outsiz profit
contribut fortun think foray
neurovascular market establish presenc
medical-surg equip help navig
provid shift moreov even orthoped
busi demonstr agil
purchas mako allow firm upsel
surgeon higher-margin implant work well
mako robot help stave price pressur
longer term think one
orthoped implant maker emerg intact
period hospit payer belt-tighten hospit
winnow vendor list midtier competitor find
difficult secur hospit contract larger
rival benefit less competit suspect
larg joint-reconstruct market consolid
evolv look much like cardiac rhythm manag
market three major manufactur control
estim market period flirt
possibl acquir smaller competitor smith
industri dynam vendor
consolid put pressur smaller firm
would surpris purchas sooner
rather later
histor leverag close relationship
surgeon get oper room think
posit strategi remain viabl medium term
surgeon could typic freelanc hospit
choic long orthoped surgeon brought
profit procedur hospit hospit will
defer orthoped procedur
profit hospit
manag profit hospit
administr assert bring cost
includ implant control
howev orthoped surgeon reluct go along
chang establish surgeon often activ
resist chang think weaken surgeon
influenc autonomi take place gradual
long time frame unlik primary-car practition
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
cardiologist repres highest proport
specialist sign hospit healthcar
system employe orthoped surgeon repres last
holdout privat practic current approxim
orthoped surgeon salari hospit system
nearli two third still privat practic
long haul proport employe orthoped
surgeon undoubtedli grow gener
chang consid current rate convers
take year orthoped surgeon reach
level hospit employ cardiologist
alreadi reach meantim orthoped surgeon
remain highli independ enjoy autonomi
increas incom fee-for-servic framework resist
hospit effort limit brand choic mani
attempt hospit made rein
analysi team formulari model -- mostli fail
far hospit consolid vendor take advantag
attract volum price success
approach think chanc
secur hospit contract enhanc
biomet part zimmer
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oth acquisit trauson extend
presenc china provid solid foothold
fast-grow chines valu segment orthoped
firm vulner on-going cost relat treat
patient
hospit healthcar system aim
consolid supplier benefit
custom like stick wide
use brand accommod surgeon
oth abil mako robot significantli improv
outcom total knee replac remain
clinic data demonstr
superior mako sale could fall quickli
oconsid resist orthoped surgeon
hospit effort restrict brand choic slow
transit hospit employ think surgeon
influenc wane slowli
oth addit physio-control unlik goos
growth opinion
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
continu enjoy extens financi flexibl
even issu debt financ purchas
larger acquisit worri stryker
pursu state plan continu acquisit
return cash sharehold dividend share
repurchas end june firm held net debt
posit billion reflect purchas
product physio-control novadaq entellu
estim debt/ebitda roughli time interest
coverag time year major debt matur
next five year includ million
million million believ
firm abl handl matur
exist cash intern gener cash flow
rate uncertainti medium reflect
wide diversifi product line-up categori
rel insul macroeconom condit like
medic devic compani expos
product failur recal result hefti legal
fee inventori write-off new emphasi
large-scal devic registri orthoped compani may
find field recal data gather
probabl surfac product problem earlier
current mechan also subject
depart justic investig past
market practic consid symbiot relationship
orthoped devic maker orthoped
surgeon could happen despit legisl
shone stronger light financi transact
manufactur surgeon sever econom condit
new realiti cost-shar increas
vulner larger trend consum spend
long term think gradual shift toward
orthoped surgeon hospit employe linchpin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
moat orthoped may need
entertain altern model sell orthoped implant
especi smith nephew syncera low-touch sale
model success
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ceo/chairman board/
repres date owner name posit common share held report holder issuer
fidel manag research compani
new york mellon corp
capit research manag compani
share
fund
share
fund
rate stewardship standard kevin lobo
step presid ceo role fall
lobo lead orthovita join
firm purchas orthovita bulk
orthobiolog offer lobo previou experi
includ time johnson johnson mcneil divis
ethicon contribut deep knowledg
healthcar market med-tech moreov bring
intern experi time canada europ
glenn boehnlein took cfo william jellison
retir strongli indic intend
expand reach faster-grow emerg market
think manag team equip make
major push area alreadi done credibl
job reorgan european oper return
region stronger growth expect much
chang strateg prioriti point lobo
underscor firm interest activ
anticip solidifi neurotechnolog
med-surg portfolio intrigu purchas
mako put influenti posit
steer applic robot surgeri joint replac
would surpris manag acquir
smith nephew next coupl year
latter sport medicin arthroscopi wound-car
busi would fit well portfolio
investor awar littl influenc may
still strong tie found
famili even though board member
consid independ would underestim
sway famili board seat vote power
well sever long-stand board member
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
expand presenc geographi
across busi jul
deliv anoth quarter stellar result
display strength across product segment
met expect top bottom line howev
well like modestli rais fair valu estim reflect
cash flow realiz sinc last updat much
common
manufactur see emerg new product market
outweigh matur slower-grow product
portfolio think current enjoy luxuri
consider portfolio former
categori latter weve long admir wide
econom moat root switch cost signific
relationship practition hospit howev
think current manag team ad topspin
savvi acquisit talent integr
second quarter particularli interest
coupl key product line first firm continu
outpac market growth knee implant year
year thank mako robot robot
placement approach weve seen
mako procedur growth gain strength think
sustain posit opinion robot
grow among practition hospit interest
use technolog patient recruit tool
second like manag recent decis separ
salesforc support wast manag power
tool focu sole concentr
rang product enjoy time build relationship
specialist practition view anoth
exampl abil manag optim labor
product similar reorgan european
structur six year ago sinc allow
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
